Virax Biolabs Group annual operating margin
2021
2023
2024
2025
Virax Biolabs Group Operating Margin Growth & History (VRAX)
Virax Biolabs Group's operating margin was −97,344.76% for fiscal 2025.
View full Virax Biolabs Group company overviewVirax Biolabs Group annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | −97,344.76% | −93191.51 pp |
| 2024 | 2024-03-31 | −4,153.25% | +62810.43 pp |
| 2023 | 2023-03-31 | −66,963.68% | −66443.14 pp |
| 2021 | 2021-04-01 | −520.54% | — |
Virax Biolabs Group quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Virax Biolabs Group operating margin trends
Across the available reported history, Virax Biolabs Group's operating margin decreased from −4,153.25% to −97,344.76%, a change of −93191.51 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Virax Biolabs Group filings at SEC.gov ↗